...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Design and Evaluation of Jingzhiguanxin Monolithic Osmotic Pump Tablet
【24h】

Design and Evaluation of Jingzhiguanxin Monolithic Osmotic Pump Tablet

机译:净之冠心整体渗透泵片的设计与评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A monolithic osmotic pump tablet(MOPT)of Traditional Chinese Medicine Compound Recipe(TCMCR)was successfully prepared and active components of Jingzhiguanxin prescription which has been widely used in China and Japan was selected as model drug.Analysis methods of maker compound in vitro of danshensu,paeoniflorin and safflor yellow A were built,and different methods were compared by f_2 factors.The results showed that there were fine correlation among them.Finally UV method of safflor yellew A was chosen to determine the release of the drugs,which was fast,convenient,met the need of determination and could represent other methods.During the research,single factor influence selection was studied emphatically.It showed that there were significant influence between different varieties and quantity of osmotic promoting agents,different kind of retardants,different varieties and quantity of PEG(polyethylene glycol)and membrane weight.However,no significant influence existed between different quantity of retardants and SDS,different membrane orifices and methods of dissolution.Based on the single factor influence selection,an optimal formulation was decided,and three maker compounds of Jingzhiguanxin MOPT could isochronous release and at the same time they had good zero order release characteristics to 8 h.Paeoniflorin release in vivo was estimated by deconvolution,the results shown that there were a good in-vitro in-vivo correlation(r=0.9571).
机译:成功制备了中药复方单片渗透泵片(MOPT),并选择了在中国和日本广泛使用的精制冠心处方的有效成分作为模型药物。丹参素的体外合成剂分析方法分别构建了pa药苷和红花黄A,并用f_2因子对不同方法进行了比较。结果表明,两者之间存在很好的相关性。最后用红花黄A的紫外光法测定了药物的释放,速度快,在研究过程中,着重研究了单因素影响选择。研究表明,不同种类和数量的渗透促进剂,不同种类的阻滞剂,不同的品种和用量对渗透系数的影响很大。 PEG(聚乙二醇)的量和膜重量。但是,不同之间没有显着影响阻滞剂和SDS的用量,不同的膜孔和溶解方法。基于单因素影响的选择,确定了最佳配方,京芝冠心MOPT的三种制造剂化合物可以等时释放,同时具有良好的零级释放特性。去卷积法估计Pa药苷在体内的释放时间为8 h。结果表明,体内Pa药苷的体内相关性良好(r = 0.9571)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号